Pictet Asset Management (UK)’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,998
| Closed | -$3.19M | – | 1024 |
|
|
2019
Q1 | $3.19M | Buy |
1,998
+673
| +51% | +$1.07M | 0.01% | 773 |
|
|
2018
Q4 | $2.48K | Buy |
1,325
+423
| +47% | +$791 | 0.01% | 799 |
|
|
2018
Q3 | $2.13M | Sell |
902
-102
| -10% | -$240K | ﹤0.01% | 870 |
|
|
2018
Q2 | $3.46M | Sell |
1,004
-112
| -10% | -$386K | 0.01% | 734 |
|
|
2018
Q1 | $3.17M | Buy |
1,116
+198
| +22% | +$562K | 0.01% | 743 |
|
|
2017
Q4 | $2.36M | Sell |
918
-110
| -11% | -$283K | 0.01% | 788 |
|
|
2017
Q3 | $2.92M | Buy |
1,028
+349
| +51% | +$990K | 0.01% | 733 |
|
|
2017
Q2 | $1.13M | Hold |
679
| – | – | ﹤0.01% | 817 |
|
|
2017
Q1 | $1.71M | Sell |
679
-540
| -44% | -$1.36M | 0.01% | 789 |
|
|
2016
Q4 | $2.75M | Sell |
1,219
-1,627
| -57% | -$3.67M | 0.01% | 694 |
|
|
2016
Q3 | $7.13M | Buy |
2,846
+1,976
| +227% | +$4.95M | 0.03% | 499 |
|
|
2016
Q2 | $2.97M | Buy |
870
+327
| +60% | +$1.12M | 0.01% | 678 |
|
|
2016
Q1 | $2.13M | Buy |
543
+21
| +4% | +$82.5K | 0.01% | 688 |
|
|
2015
Q4 | $2.68M | Sell |
522
-252
| -33% | -$1.29M | 0.01% | 681 |
|
|
2015
Q3 | $2.46M | Sell |
774
-454
| -37% | -$1.44M | 0.01% | 695 |
|
|
2015
Q2 | $5.07M | Buy |
1,228
+325
| +36% | +$1.34M | 0.02% | 584 |
|
|
2015
Q1 | $3.26M | Buy |
903
+93
| +11% | +$335K | 0.01% | 672 |
|
|
2014
Q4 | $3.97M | Buy |
810
+23
| +3% | +$113K | 0.02% | 636 |
|
|
2014
Q3 | $3.2M | Sell |
787
-371
| -32% | -$1.51M | 0.02% | 654 |
|
|
2014
Q2 | $4.69M | Buy |
1,158
+272
| +31% | +$1.1M | 0.02% | 563 |
|
|
2014
Q1 | $4.03M | Buy |
886
+48
| +6% | +$218K | 0.02% | 588 |
|
|
2013
Q4 | $2.94M | Sell |
838
-250
| -23% | -$876K | 0.02% | 656 |
|
|
2013
Q3 | $4.47M | Sell |
1,088
-543
| -33% | -$2.23M | 0.03% | 540 |
|
|
2013
Q2 | $6.46M | Buy |
+1,631
| New | +$6.46M | 0.04% | 422 |
|